Back to search
Tropical Infectious Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tropical Infectious Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Tropical Infectious Disease trials you may qualify forObjective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less tha…
This multicenter, randomized, open-label Phase 2 clinical trial evaluates the safety, tolerability, and virologic efficacy of ARN-75039, a novel oral antiviral,…
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
Chagas disease (CD) is the most significant endemic zoonosis in Argentina. Two-thirds of affected individuals live in urban areas but only 10% globally are awar…
This clinical trial compares two treatments - ivermectin and moxidectin - to learn which is better at reducing the proportion of people with onchocerciasis (riv…
Travellers returning from tropical countries often present to emergency departments with acute fever. While systematic screening for malaria is well established…
This phase 2b, open-label, randomized controlled trial evaluates the efficacy and safety of dolutegravir (DTG) alone versus dolutegravir combined with tenofovir…
This is a multi-site, observational, cross-sectional clinical study that includes geographically diverse sites within and outside the United States.